(VIANEWS) – NASDAQ Composite ended the session with Castle Biosciences jumping 2.44% to $68.73 on Wednesday, following the last session’s upward trend. NASDAQ Composite jumped 0.92% to $14,631.95, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Today’s last reported volume for Castle Biosciences is 149735, 40.82% below its average volume of 253007.
Castle Biosciences’s last close was $67.09, 37.7% below its 52-week high of $107.69.
The company’s growth estimates for the current quarter and the next is a negative 362.5% and a negative 47.8%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 31%, now sitting on 68.04M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Castle Biosciences’s stock is considered to be overbought (>=80).
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $68.73 at 18:02 EST, way below its 52-week high of $107.69 and way above its 52-week low of $36.15.
Castle Biosciences’s Moving Average
Castle Biosciences’s worth is below its 50-day moving average of $70.51 and below its 200-day moving average of $70.47.
More news about Castle Biosciences (CSTL).